{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:40Z","timestamp":1787022100468,"version":"build-2736575974"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Reports of potential treatment failure have raised particular concerns regarding the efficacy of the single dose azithromycin regimen in the treatment of urogenital and anorectal\n                    <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                    (CT) infections. Several factors have been suggested, including heterotypic resistance. Antimicrobial susceptibility testing in CT requires cell culture with serial dilutions of antibiotics, which is laborious and for which there is no standardized testing methodology. One method to partly overcome these difficulties would be to use a genotypic resistance assay, however most current available assays do still require prior CT culture. In order to facilitate the assessment of genotypic resistance directly from clinical samples, without the need for prior culture, the aim of this study was to develop a CT specific PCR assay for the assessment of resistance associated mutations (RAMs) in the 23S rRNA gene, and to evaluate a sample of clinical cases in which CT PCR\u2019s remained positive during follow-up despite azithromycin treatment. Neither the\n                    <jats:italic>in silico<\/jats:italic>\n                    analysis nor the analytical specificity testing demonstrated clinically relevant cross-reactivity with other bacterial species. These results in conjunction with the analytical sensitivity demonstrating consistent CT 23S rRNA gene detection in the range of 10e3 IFU\/mL, exemplify the assay\u2019s apt performance. Although no known macrolide RAMs were detected in the clinical cases, the described assay allows future culture independent macrolide RAM surveillance in CT, and increases accessibility for other laboratories to engage in screening.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0265229","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T13:57:51Z","timestamp":1652191071000},"page":"e0265229","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3611-7732","authenticated-orcid":true,"given":"J. M.","family":"van Niekerk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. H. M.","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Morr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-0974","authenticated-orcid":true,"given":"C. J. P. A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H. T. M.","family":"Dukers-Muijrers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. F. G.","family":"Wolffs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"pone.0265229.ref001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12879-015-1030-9","article-title":"Treatment challenges for urogenital and anorectal Chlamydia trachomatis","volume":"15","author":"FY Kong","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"pone.0265229.ref002","doi-asserted-by":"crossref","first-page":"e81236","DOI":"10.1371\/journal.pone.0081236","article-title":"Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms","volume":"8","author":"NH Dukers-Muijrers","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"pone.0265229.ref003","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/cid\/ciz050","article-title":"Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure).","volume":"69","author":"N Dukers-Muijrers","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0265229.ref004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials","volume":"59","author":"FY Kong","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0265229.ref005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0956462415618837","article-title":"2015 European guideline on the management of Chlamydia trachomatis infections","volume":"27","author":"E Lanjouw","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"4","key":"pone.0265229.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021.","volume":"70","author":"KA Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"pone.0265229.ref007","author":"B Dragovic","year":"2018"},{"issue":"5","key":"pone.0265229.ref008","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/jac\/dky548","article-title":"Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review","volume":"74","author":"FY Kong","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"pone.0265229.ref009","first-page":"1","article-title":"Azithromycin in the treatment of rectogenital Chlamydia trachomatis infections: end of an era?","author":"MR Hammerschlag","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"pone.0265229.ref010","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1017\/S0950268816000996","article-title":"Higher organism load associated with failure of azithromycin to treat rectal chlamydia","volume":"144","author":"FY Kong","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"3","key":"pone.0265229.ref011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"PJ Horner","year":"2012","journal-title":"Sex Transm Infect"},{"key":"pone.0265229.ref012","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/4611","article-title":"Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs","volume":"23","author":"T Mestrovic","year":"2018","journal-title":"Front Biosci (Landmark Ed)."},{"key":"pone.0265229.ref013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fcimb.2014.00071","article-title":"Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns","volume":"4","author":"ME Lewis","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"pone.0265229.ref014","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.48.4.1347-1349.2004","article-title":"Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides","volume":"48","author":"OY Misyurina","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0265229.ref015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"R. Leclercq","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0265229.ref016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568005043340777","article-title":"Macrolide resistance based on the Erm-mediated rRNA methylation.","volume":"4","author":"G. Maravi\u0107","year":"2004","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"9","key":"pone.0265229.ref017","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/AAC.48.9.3586-3590.2004","article-title":"Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae","volume":"48","author":"PF Riska","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0265229.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","article-title":"Macrolide resistance conferred by base substitutions in 23S rRNA","volume":"45","author":"B Vester","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pone.0265229.ref019","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/162.6.1309","article-title":"Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics","volume":"162","author":"RB Jones","year":"1990","journal-title":"J Infect Dis"},{"issue":"4","key":"pone.0265229.ref020","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/315372","article-title":"Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure","volume":"181","author":"J Somani","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0265229.ref021","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000314998","article-title":"Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.","volume":"56","author":"AR Bhengraj","year":"2010","journal-title":"Chemotherapy"},{"key":"pone.0265229.ref022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2020.03.015","article-title":"High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection","volume":"96","author":"L Shao","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"pone.0265229.ref023","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10517-007-0221-9","article-title":"Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy","volume":"143","author":"MM Shkarupeta","year":"2007","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"pone.0265229.ref024","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3892\/etm.2015.2595","article-title":"Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates","volume":"10","author":"Y Jiang","year":"2015","journal-title":"Exp Ther Med"},{"issue":"Rr-02","key":"pone.0265229.ref025","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014.","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"pone.0265229.ref026","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/AAC.47.2.636-642.2003","article-title":"Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp","volume":"47","author":"RJ Suchland","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0265229.ref027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000007192","article-title":"Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics","volume":"45","author":"T Notomi","year":"1999","journal-title":"Chemotherapy"},{"issue":"6","key":"pone.0265229.ref028","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/428290","article-title":"Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report","volume":"191","author":"SA Wang","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"pone.0265229.ref029","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jcp.2004.021543","article-title":"Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum","volume":"58","author":"JM Lyons","year":"2005","journal-title":"J Clin Pathol"},{"issue":"12","key":"pone.0265229.ref030","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1128\/AAC.00962-07","article-title":"Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2","volume":"51","author":"R Binet","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0265229.ref031","doi-asserted-by":"crossref","first-page":"126200","DOI":"10.1016\/j.syapm.2021.126200","article-title":"Evidence for the existence of a new genus Chlamydiifrater gen. nov. inside the family Chlamydiaceae with two new species isolated from flamingo (Phoenicopterus roseus): Chlamydiifrater phoenicopteri sp. nov. and Chlamydiifrater volucris sp. nov","volume":"44","author":"F Vorimore","year":"2021","journal-title":"Syst Appl Microbiol"},{"issue":"5","key":"pone.0265229.ref032","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7050146","article-title":"Chlamydiaceae: Diseases in Primary Hosts and Zoonosis","volume":"7","author":"HC Cheong","year":"2019","journal-title":"Microorganisms"},{"issue":"3","key":"pone.0265229.ref033","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/tbed.12446","article-title":"Assessment of Chlamydia suis Infection in Pig Farmers.","volume":"64","author":"L De Puysseleyr","year":"2017","journal-title":"Transbound Emerg Dis"},{"key":"pone.0265229.ref034","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s12879-014-0560-x","article-title":"Evaluation of the presence and zoonotic transmission of Chlamydia suis in a pig slaughterhouse","volume":"14","author":"K De Puysseleyr","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"pone.0265229.ref035","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1128\/AAC.48.10.3989-3995.2004","article-title":"Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene","volume":"48","author":"J Dugan","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pone.0265229.ref036","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/AAC.01321-09","article-title":"Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs","volume":"54","author":"R Binet","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"pone.0265229.ref037","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/nar\/24.14.2701","article-title":"The influence of base identity and base pairing on the function of the alpha-sarcin loop of 23S rRNA","volume":"24","author":"M O\u2019Connor","year":"1996","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T13:58:32Z","timestamp":1652191112000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265229"}},"subtitle":[],"editor":[{"given":"Deborah","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0265229","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}